Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Sodium phenylbutyrate for improving insulin sensitivity in type 2 diabetes
NL-OMON48748Active, not recruiting
- Sponsor
- Maastricht University
- Start
- Apr 2019
- Modality
- Small Molecules
- Countries
- 1
01
Overview
Trial of sodium phenylbutyrate in type 2 diabetes mellitus (T2DM) and insulin resistance (IR) (2 arms), sponsored by Maastricht University. Primary endpoint: Change in whole-body insulin sensitivity. Started Apr 2019; status: active, not recruiting.
02
Drugs
sodium phenylbutyrate
03
Conditions
type 2 diabetes mellitus (T2DM)insulin resistance (IR)
Beyond the preview
Go deeper on NL-OMON48748.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NL-OMON48748.